Enzyme engineering, precision fermentation, botanical synthesis and smarter formulation are changing how the food industry approaches sweetness. But the real test for these technologies will be their ability to deliver the taste, functionality and economics that manufacturers need.
For the food industry, reducing sugar has become one of the most persistent formulation challenges. Consumer interest in healthier choices continues to influence product development, while manufacturers face growing pressure to lower sugar content without compromising the taste and experience that keep consumers coming back.
The difficulty is that sugar does considerably more than make food taste sweet. In a soft drink, it contributes to body and mouthfeel. In bakery products, it influences browning, moisture retention and structure. In confectionery, it helps determine texture and stability. Simply removing it can therefore create a chain of formulation problems that a high-intensity sweetener alone cannot solve.
This explains why sweetener innovation is moving in several directions at once. The industry is not just looking for another ingredient to replace sucrose. It is exploring new ways to produce sweet molecules, improve the sensory performance of existing ingredients and develop combinations that can reproduce more of sugar’s functional contribution.
Recent developments suggest that this shift is gathering momentum. From enzyme-based production of steviol glycosides to commercial investment in sweet proteins, the technologies shaping the next generation of sweeteners are beginning to move beyond research laboratories. Five developments, in particular, deserve closer attention.
Re-engineering sweetness through enzymes
One of the clearest examples of how sweetener production is changing can be seen in the development of stevia-based ingredients.
Stevia has established a strong position in sugar-reduction strategies, but not all steviol glycosides deliver the same sensory experience. Some are associated with lingering sweetness or bitter notes, while rebaudioside M (Reb M) has attracted considerable interest for its more sugar-like taste profile. The challenge is that Reb M occurs naturally in relatively small quantities in the stevia leaf, making extraction an important supply and cost consideration.
Enzymatic bioconversion offers a way around this limitation. Rather than depending entirely on the concentration of a particular glycoside in the plant, manufacturers can use specialised enzymes to convert more abundant steviol glycosides into targeted compounds. The approach allows production to be directed towards the molecules that offer the desired taste characteristics.
This is more than a technical adjustment to an existing ingredient. It represents a change in how manufacturers think about the relationship between agricultural raw materials and the final sweetener. The value of the plant is no longer determined only by the amount of a desirable compound it naturally contains; biotechnology can help transform the available material into a more targeted ingredient.
The regulatory progress of enzymatically produced steviol glycosides also illustrates how important these manufacturing routes are becoming. In September 2026, the European Food Safety Authority published a scientific opinion evaluating a modified manufacturing process for enzymatically produced steviol glycosides, including the use of enzymes produced through a genetically modified E. coli strain. The assessment reflects the growing importance of evaluating not only the final ingredient but also the processes used to manufacture it.
For ingredient producers, the opportunity lies in improving conversion efficiency, product consistency and access to desirable glycosides. However, the economics will depend on more than enzyme performance. Substrate costs, reaction yields, purification requirements and manufacturing scale will all influence whether enzymatic production can compete with conventional extraction and other routes.
Precision fermentation takes sweet proteins closer to scale
While enzyme engineering is helping manufacturers improve access to existing sweet molecules, precision fermentation is opening the door to a different category of ingredients: sweet proteins.
Proteins such as brazzein have attracted interest because they can deliver intense sweetness at very low concentrations. Their appeal lies in the possibility of achieving a different sensory profile from conventional high-intensity sweeteners. Yet producing these proteins in commercially meaningful quantities has been a significant challenge.
Precision fermentation provides an alternative to relying on natural extraction. By using selected microorganisms as production hosts, companies can develop controlled processes for manufacturing specific proteins. In principle, this offers a more scalable route to ingredients that may be difficult or inefficient to obtain from their natural sources.
The technology is now attracting investment in dedicated manufacturing infrastructure. In September 2026, Bestzyme, a subsidiary of GenScript Biotech, announced the completion of a dedicated sweet-protein production line in Jinan, China. The facility is intended to support the commercial scale-up of its brazzein-based ingredient, Mellia®. The development is notable because it moves the conversation beyond the potential of sweet proteins and towards the practical requirements of producing them at industrial scale.
That distinction matters. A sweet protein may demonstrate an attractive sweetness profile in laboratory testing, but commercial adoption will depend on whether it can be manufactured consistently, recovered efficiently and supplied at a cost that food and beverage manufacturers can justify.
There are also application questions to resolve. Heat stability, pH tolerance, solubility and performance in different food matrices will determine where these ingredients can be used. A protein that works well in one beverage formulation may require further development before it can perform in dairy, confectionery or baked products.
Precision fermentation therefore represents an important opportunity, but its success will be measured by more than production capacity. The industry will need to see evidence that these ingredients can deliver reliable performance in finished products and fit into existing manufacturing and regulatory frameworks.
Botanical synthesis offers another route to plant-derived sweetness
The search for new sweetening ingredients is also changing the way companies approach botanical production.
Traditionally, plant-derived ingredients have depended on cultivation, harvesting and extraction. This model remains essential, but it can expose manufacturers to variations in crop quality, climate conditions, agricultural availability and the concentration of target compounds. For ingredients that occur naturally in small quantities, these limitations can become particularly important.
Botanical synthesis is exploring an alternative. Rather than growing the entire plant and extracting the desired compounds, the approach uses plant-cell-based systems to produce targeted botanical compositions under controlled conditions. The aim is to develop a more consistent production route while reducing dependence on conventional agricultural cultivation for selected ingredients.
The technology has started to attract interest from established ingredient companies looking to broaden their sweetener development capabilities. In October 2026, Tate & Lyle and BioHarvest Sciences announced a milestone in their next-generation sweetener programme, confirming that BioHarvest’s Botanical Synthesis™ platform had demonstrated the ability to produce the targeted sweetening solution.
The announcement is an important indication of technical progress, although it should not be confused with a fully commercialised ingredient launch. The programme remains under development. What makes the collaboration particularly interesting is the combination of BioHarvest’s production platform with Tate & Lyle’s experience in sweetening, formulation and customer applications.
This is where the commercial relevance of botanical synthesis becomes clearer. A new production technology has limited value if it cannot deliver an ingredient that manufacturers can use consistently and economically. The ability to control production, maintain composition and establish a dependable supply could become an advantage, particularly where conventional sourcing is constrained.
The next stage will be to establish how the process performs at scale, what production costs look like and how the resulting ingredient compares with existing alternatives. For now, botanical synthesis is best viewed as an emerging route with potential, rather than a proven replacement for conventional plant extraction.
AI is changing how researchers search for sweetness
The development of new sweeteners has traditionally involved considerable experimentation. Researchers must identify candidate molecules, assess their interaction with taste receptors, evaluate sweetness intensity and investigate undesirable characteristics such as bitterness or lingering aftertaste. Each stage can require extensive laboratory work.
Artificial intelligence is beginning to offer a more targeted way to approach this process.
Machine-learning models can analyse molecular structures and identify patterns associated with different taste characteristics. By using existing datasets, researchers can screen compounds computationally and prioritise those that appear more likely to deliver the desired sensory properties. Similar approaches can help investigate bitterness and predict how different sweetener combinations may behave.
Research published in the Journal of Food Composition and Analysis in February 2026 introduced TasteMolNet, a machine-learning platform designed to predict sweet, bitter and tasteless compounds. The researchers combined computational modelling with electronic-tongue testing and molecular docking to evaluate the model. The study reported an F1 score of 88% for its optimised prediction model, illustrating how computational tools could support the early stages of taste research.
The significance is not that AI can independently identify the next successful commercial sweetener. Sensory perception is complex, and a predicted sweet molecule still needs to be tested for safety, stability, taste quality and performance in real food systems. Rather, these tools could help researchers narrow the field and make experimental development more focused.
For ingredient companies, the longer-term opportunity may lie in connecting molecular data with formulation knowledge. Predicting that a compound is sweet is one thing; understanding how it behaves alongside acids, flavours, proteins, fibres and other ingredients is another. Bringing these data sets together could make sweetener development more efficient and help companies move from molecule discovery towards application-ready solutions.
The formulation challenge: sweetness is not the same as sugar replacement
Even as new molecules and production technologies emerge, one of the most immediate changes in the market is happening at the formulation level.
For manufacturers, the objective is rarely to replace sweetness alone. A reduced-sugar beverage may need additional ingredients to restore body and mouthfeel. A bakery product may require adjustments to moisture, browning and structure. A confectionery formulation may need a different combination of sweeteners and bulking agents to achieve the expected texture.
This is why the industry is increasingly moving towards integrated sweetening systems. Instead of relying on a single ingredient, formulators combine high-intensity sweeteners with other components such as rare sugars, polyols, fibres, starches and flavour-modulating ingredients. The combination is designed around the product’s specific requirements.
Recent product development illustrates that the market is not moving exclusively towards zero-sugar solutions. In October 2026, Cargill introduced its Craftiva™ range of reduced-sugar syrups and sweetener packets. Its flavoured syrups contain seven grams of sugar per serving, compared with approximately 20 grams in the leading national-brand syrup cited by the company. The formulation combines cane sugar, stevia sweetener and sea salt.
The launch reflects an important commercial reality: some consumers want to reduce sugar without necessarily eliminating it. For manufacturers, this creates room for products that sit between conventional full-sugar formulations and completely sugar-free alternatives.
It also reinforces the importance of formulation expertise. A successful reduced-sugar product is not necessarily the one with the highest proportion of an alternative sweetener. It is the one that achieves the right balance of taste, texture, nutrition, label expectations and cost.
For ingredient suppliers, this creates opportunities beyond the sale of individual sweetening ingredients. Companies with capabilities across sweeteners, flavours, fibres and texturants are better positioned to develop complete solutions for specific applications. The ability to understand how ingredients interact in a finished product can become as important as the ingredient itself.
The next competitive advantage will be built beyond the molecule
Taken together, these developments point to a broader change in the sweetener industry. Innovation is no longer concentrated in the discovery of high-intensity sweeteners or the extraction of naturally occurring compounds. It is spreading across production technology, molecular design, sensory research and formulation.
However, the pace of technical development should not be mistaken for immediate commercial readiness. Enzyme-based production must demonstrate competitive yields and efficient purification. Sweet proteins need dependable manufacturing economics and application validation. Botanical synthesis must establish reproducibility and scale. AI-driven discovery needs to translate predictions into ingredients that perform outside the laboratory. And integrated sweetening systems must deliver a clear benefit without adding unacceptable formulation costs.
These challenges will shape which technologies move beyond pilot projects and become meaningful parts of the global ingredient supply chain.
They will also influence how companies compete. A differentiated sweetener molecule may attract attention, but long-term advantage is more likely to come from the combination of a reliable production process, consistent quality, regulatory readiness and the ability to solve real formulation problems for customers.
The future of sweetener innovation, therefore, is unlikely to be defined by one breakthrough ingredient that replaces sugar across every category. Different applications will continue to require different approaches. What is changing is the industry’s ability to engineer those approaches with greater precision.
The question is no longer simply what can make a product sweet. It is how that sweetness can be produced, delivered and experienced in a way that meets the increasingly demanding expectations of manufacturers and consumers alike.
